Female, 50 y/o

Patient internal ID: 822117688

ICD-10 code

C50.9 Malignant Neoplasm Breast, Unspecified

Diagnosis (incl metastases/stage) and year

May 2020
Right Breast Carcinoma ypT0ypN0sn(0/1) LV0, ER(-), PR(-), HER(-), Ki67 – 70-80%.

Previous treatment

Chemotherapy (Carboplatin/Paclitaxel), Surgery, Radiation Therapy.

Prognosis and survival expectation

The five-year relative survival rate for patients with Localized Triple-Negative Breast Cancer is 91%.

Treatment provided

Autologous DCV over a period of 12 months. Additionally, the patient received Immunostimulation of Interferon (IFN) β and Tumor Necrosis Factor (TNF).

Patient survival/condition and year

The patient has survived for 3,5 years since the diagnosis with no signs of disease. The patient is attending regular follow-ups. It can be concluded that the addition of Immunotherapy, alongside Chemotherapy, Surgery and Radiation Therapy ,has benefited patient with disease stabilisation.

Date of Review